KindlyMD (NASDAQ:NAKA) Issues Earnings Results

KindlyMD (NASDAQ:NAKA) posted its quarterly earnings data on Thursday. The company reported ($1.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.49) by ($0.91), Zacks reports. KindlyMD had a negative net margin of 1,067.93% and a negative return on equity of 63.45%.

KindlyMD Trading Down 7.4%

NASDAQ NAKA traded down $0.46 during trading hours on Thursday, reaching $5.79. 144,618 shares of the company traded hands, compared to its average volume of 197,276. KindlyMD has a 12 month low of $3.33 and a 12 month high of $26.00. The stock has a market capitalization of $106.22 million, a PE ratio of -0.16 and a beta of 16.03. The company has a 50 day moving average of $7.98 and a two-hundred day moving average of $7.62.

Wall Street Analyst Weigh In

Several research analysts recently commented on NAKA shares. B. Riley Financial boosted their price target on KindlyMD from $11.00 to $13.00 and gave the stock a “buy” rating in a research note on Tuesday, September 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of KindlyMD in a research note on Wednesday, November 4th. Finally, TD Cowen raised their price objective on KindlyMD from $1.00 to $17.00 and gave the company a “buy” rating in a research note on Monday, July 27th. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, KindlyMD currently has an average rating of “Moderate Buy” and an average price target of $20.00.

Insiders Place Their Bets

In related news, CEO David F. Bailey bought 32,134 shares of the company’s stock in a transaction dated Wednesday, August 19th. The stock was bought at an average price of $5.59 per share, with a total value of $179,629.06. Following the transaction, the chief executive officer owned 32,134 shares of the company’s stock, valued at approximately $179,629.06. This trade represents a ? increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Over the last ninety days, insiders have acquired 41,904 shares of company stock worth $235,231. 24.08% of the stock is owned by company insiders.

KindlyMD Company Profile

KindlyMD, Inc. is a healthcare company focused on providing integrated care for patients dealing with chronic pain, behavioral health conditions and substance-use disorders. The company emphasizes a patient-centered approach that combines medical treatment, behavioral health support and other services designed to address the underlying factors affecting a patient’s health and quality of life. KindlyMD’s services include chronic pain evaluation and management, medication-assisted treatment for opioid-use disorder, behavioral health care and related primary or supportive healthcare services.